{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Chemotherapy - Induced Peripheral Neuropathy

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Apply evidence-based guidelines for assessing patients prior to chemotherapy who are at risk for developing CIPN.
  2. Monitor patients for symptoms of CIPN during and after chemotherapy.
  3. Select evidence-based guidelines for managing CIPN.
Price: $17.95


  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Test Code: AJN0421A
Published: April 2021
Expires: 3/3/2023
Required Passing Score: 7/10 (70%)
Authors: Robert Knoerl, PhD, RN